Clinical Trials of Isotine Plus Ayurvedic Eye Drops Show Significant Improvement in Cataract Patients


Key Highlights :

1. Jagat Pharma has been accredited with the WHO-GMP and Certificate of Pharmaceutical Products (CoPP) for its Isotine Plus ayurvedic eye drops.
2. The Isotine Plus eye drops have been clinically used for 36 years.
3. The results of a retrospective observational study conducted by Prof Yamini of Banaras Hindu University, Uttar Pradesh, on the use of Isotine Plus showed a significant improvement in uncorrected distance visual acuity (UDVA) and uncorrected near visual acuity (UNVA).
4. Around a million units of these eye drops have been sold during 2022-23.




     Uttar Pradesh-based Jagat Pharma has been accredited with the WHO-GMP (World Health Organisation-Good Manufacturing Practices) certificate and Certificate of Pharmaceutical Products (CoPP) for its Isotine Plus ayurvedic eye drops. This is the first time any ayurvedic eye drop manufactured in the country has received the WHO-GMP and the CoPP certificate. The Isotine Plus eye drops have been clinically used for 36 years and Jagat Pharma has successfully conducted clinical trials on Isotine Plus eye drops in patients suffering from immature cataract and other complex eye problems.

     Recently, Jagat Pharma announced the results of a retrospective observational study conducted by Prof Yamini of Banaras Hindu University, Uttar Pradesh, on the use of Isotine Plus. The study, which included 308 cataract patients, treated during 2017-19, showed a significant improvement in uncorrected distance visual acuity (UDVA) and uncorrected near visual acuity (UNVA) after treatment with Isotine Plus. Around a million units of these eye drops have been sold during 2022-23.

     The WHO-GMP and CoPP certificates for Isotine Plus eye drops is a major achievement for Jagat Pharma and the results of the study conducted by Prof Yamini further reinforces the efficacy of the product. This will encourage more people to opt for the ayurvedic eye drops and help them in managing their eye problems. The company’s focus on R&D will also help in further improving the quality and efficacy of the product.

     It is important to note that Isotine Plus is not a substitute for medical treatment and should not be used as a replacement for any medical advice given by a doctor. It is recommended to consult an ophthalmologist before using the product. Furthermore, the product should be used as per the instructions given by the manufacturer and should not be taken in excess.

     In conclusion, the WHO-GMP and CoPP certificates and the results of the study conducted by Prof Yamini are a testament to the efficacy of Isotine Plus ayurvedic eye drops. It is a safe and effective way of managing eye problems and should be used as per the instructions given by the manufacturer.



Continue Reading at Source : financialexpress